InvestorsHub Logo
Followers 260
Posts 19732
Boards Moderated 0
Alias Born 10/03/2004

Re: starfire post# 1485

Monday, 07/31/2006 3:49:52 PM

Monday, July 31, 2006 3:49:52 PM

Post# of 146279
I agree with your take on this. The GSK PR was unfiltered by the press, and met uncritically by the market analysts. The thing is, the statement that the drug is a major setback for everyone else is a total overreach. The drug is still preclinical, the same as most others, and by their own admission still has a long way to go before market.

doc.feelgoode@yahoo.com

"It ain't what they call you, it's what you answer to." --WC Fields


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News